丙型肝炎病毒包膜蛋白E2与CD81关系的研究进展
被引量：2
Research Progress in the Relationship of the Envelop Protein E2 of Hepatitis C and CD81
摘要
丙型肝炎病毒(HCV)是慢性肝炎的主要病因之一,其基因组为单股正链RNA,包膜蛋白E2在HCV入侵宿主细胞中起重要作用,CD81可能是HCV的受体或共同受体,进一步研究CD81和HCV E2的相互作用,有助于HCV的治疗和预防。
出处
《热带医学杂志》
CAS
2003年第1期109-112,共4页
Journal of Tropical Medicine
参考文献24
-
1[1]Choo QL,Kuo G,Weiner AJ,et al.Isolation of a cDNA clone derived from a blood-borne non-A,non-B viral hepatitis genome[J]. Science,1989;244(4902):359-362.
-
2[2]Lohmann V,Koch JO,Bartenschlager R.Processing pathways of the hepatitis C virus proteins[J].J Hepatol,1996; 24(2):11-19.
-
3[3]Lagging LM,Meyer K,Owens RJ,et al. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus[J]. J Virol,1998;72(5):3539-3546.
-
4[4]Oren R,Takahashi S,Doss C,et al. TAPA-1,the target of an antiproliferative antibody,defines a new family of transmembrane proteins[J].Mol Cell Biol,1990;10(8):4007.
-
5[5]Wright MD,Tomlinson MG. The ins and outs of the transmembrane 4 superfamily[J].Immunol Today,1994;15:588-594.
-
6[6]Andria ML,Hsieh CL,Oren R,et al. Genomic organization and chromosomal localization of the TAPA-1 gene[J].J Immunol,1991;147(3):1030-1036.
-
7[7]Higginbottom A,Quinn ER,Kuo CC,et al. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2[J].J Virol,2000;74:3642-3649.
-
8[8]Levy S,Todd SC,Maecker HT. CD81(TAPA-1):A molecule in volved in signal transduction and cell adhesion in the immune system[J]. Annual Review of Immun,1998,16:89-109.
-
9[9]Meola A,Sbardellati A,Bruni Ercole B,et al. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection[J].J Virol,2000;74:5933-5938.
-
10[10]Maecker HT,Todd SC,Kim EC,et al. Differential expression of murine CD81 highlighted by new anti-mouse CD81 monoclonal antibodies[J]. Hybridoma,2000;19:15-22.
同被引文献29
-
1鈴木健介,白辑五.丙型肝炎病毒分子机制在临床的应用[J].日本医学介绍,2004,25(8):351-353. 被引量：1
-
2楚莉辉,李琦涵.丙型肝炎DNA疫苗研究进展[J].国外医学（病毒学分册）,2004,11(5):141-145. 被引量：4
-
3赵平,戚中田.丙型肝炎疫苗相关研究进展[J].肝脏,2004,9(4):258-260. 被引量：1
-
4王雷,扈荣良.丙型肝炎病毒感染动物模型研究进展[J].中国生物制品学杂志,2007,20(8):617-619. 被引量：4
-
5Pavio N,Lai MMC.The hepatitis C virus persistence:how to evade the immune system?.J Biosci,2003,28(3):287-304.
-
6Farci P,Bukh J,Purcell RH.The quasispecies of hepatitis C virus and the host immune response.Springer Semin Immunopathol,1997,19(1):5-26.
-
7Kumar U,Monjardino J,Thomas HC.Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.Gastroenterology,1994,106(4):1072-1075.
-
8Booth JC,Kumar U,Webster D,et al.Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients.Hepatology,1998,27(1):223-227.
-
9Cucchiarini M,Kammer AR,Grabscheid B,et al.Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.Cell Immunol,2000,203(2):111-123.
-
10He XS,Rehermann B,Lopez-Labrador FX,et al.Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.Proc Natl Acad Sci USA,1999,96(10):5692-5697.
-
1代志琰.丙型肝炎病毒包膜蛋白E2与 CD81关系的研究进展[J].中山大学研究生学刊（自然科学与医学版）,2003,24(2):27-33. 被引量：1
-
2杨斌,宋春辉,迟淑萍,陈黎明,程云.HCV包膜蛋白E2高变区1模拟肽诱导小鼠树突状细胞免疫应答机制的实验研究[J].军医进修学院学报,2011,32(4):363-365. 被引量：2
-
3钟彦伟,成军,施双双,王刚,夏小兵,田小军,李莉,张玲霞,陈菊梅.人源抗丙型肝炎病毒包膜蛋白E2单链抗体的研究[J].中华肝脏病杂志,2002,10(2):109-112. 被引量：16
-
4代志琰,李刚,徐启桓,姚集鲁,韩晓燕,杨林,陈文思.丙型肝炎病毒包膜蛋白E2的原核表达及鉴定[J].中山大学学报（医学科学版）,2006,27(1):83-85.
-
5钟彦伟,成军,施双双,王刚,陈菊梅.丙型肝炎病毒包膜蛋白E2人源单链可变区抗体的筛选与鉴定[J].解放军医学杂志,2003,28(1):53-54. 被引量：3
-
6朱珺,王春林,朱立新,孔玉英,汪垣,李光地.丙型肝炎病毒包膜蛋白E2的DNA免疫[J].生物化学与生物物理学报,2002,34(4):445-451. 被引量：1
-
7刘霜,鞠鹤鹏,戚中田,边中启,秦照玲.丙型肝炎病毒包膜蛋白E2中关键组氨酸位点突变体的构建与感染性[J].中国生物制品学杂志,2012,25(5):531-535.
-
8郭振华,景涛.丙型肝炎病毒传播研究新进展[J].临床消化病杂志,2005,17(2):91-93. 被引量：9
-
9马保凤.隐匿性HCV感染[J].肝脏,2012,17(12):890-894. 被引量：1
-
10徐东平,周先志.丙型肝炎抗病毒治疗药物研究进展[J].传染病信息,2008,21(4):210-213. 被引量：15
